Research Progress on the Combination Therapy of EGFR-TKIs and Metformin 
in Acquired Resistance to EGFR-TKIs in Non-small Cell Lung Cancer

Research Progress on the Combination Therapy of EGFR-TKIs and Metformin 
in Acquired Resistance to EGFR-TKIs in Non-small Cell Lung Cancer

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) targeting EGFR are effective in EGFR mutation-positive non-small cell lung cancer (NSCLC) patients, but drug resistance is inevitable. With the application and expansion of individualized and combined therapy, more and more stud...

全面介绍

书目详细资料
Main Authors: Jiamin WANG, Pan LIU, Lisha YING, Rui ZHU, Chaodan YANG, Ying YANG, Dan SU
格式: 文件
语言:zho
出版: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2023-11-01
丛编:Chinese Journal of Lung Cancer
主题:
epidermal growth factor receptor-tyrosine kinase inhibitors
metformin
targeted therapy
lung neoplasms
combined therapy
在线阅读:http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.22

因特网

http://dx.doi.org/10.3779/j.issn.1009-3419.2023.106.22

相似书籍